{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:30:39Z","timestamp":1787070639265,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Molecular confirmation of histologic diagnosis has become mandatory for the diagnosis of Ewing sarcoma family of tumors (ESFT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To validate the diagnosis made by morphology and immunohistochemistry (IHC) by fluorescence in-situ hybridization (FISH) for EWSR1 rearrangement on formalin fixed paraffin embedded (FFPE) tissues. Settings and design: A retrospective and prospective observational study. Material and methods: All patients who had FISH studies for EWSR1 rearrangement for small round cell tumors during 10 years period were included. Demographic, clinical and radiological details were obtained from medical records. Morphology was reviewed with IHC by CD99, FLI1 and others. FISH studies were performed using the break apart probe. Additional molecular studies and IHC were done to resolve the diagnosis in EWSR1 rearranged tumors. Final diagnosis was made by integrating clinical, morphology, IHC and molecular features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There were 81 patients (M: F 45:36, median age 21 years) with 32 skeletal and 49 extra skeletal tumors. CD 99 was positive in 94.52%. FISH for EWSR1 were positive in 59, negative in 13 and failed in 9. The final diagnosis was made as ESFT in 67, angiomatoid fibrous histiocytoma in 3, desmoplastic small round cell tumor in 3, myxoid chondrosarcoma in 2, unclassified in one, synovial sarcoma in 3, and one each of lymphoma and small cell neuroendocrine carcinoma. FISH was positive for ESFT in 89.83% of EWSR1 rearranged tumors. FISH validated the diagnosis made on IHC in 79.10%. FISH resolved the diagnosis in 1.49% CD99 negative tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>FISH is a reliable ancillary technique for the diagnosis of ESFT on FFPE tissues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpm.ijpm_267_20","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T04:04:25Z","timestamp":1717041865000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["FISH for EWSR1 in Ewing's sarcoma family of tumors"],"prefix":"10.4103","volume":"64","author":[{"given":"Sudha S.","family":"Murthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya Devi","family":"Gundimeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Manjula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil J.","family":"Rajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. V. V.","family":"N Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Subramanyeshwar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20240829","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJM199408043310503","article-title":"The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts","volume":"331","author":"Delattre","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-17-20240829","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jmoldx.2011.01.004","article-title":"Molecular diagnosis in Ewing family tumors: The Rizzoli experience-222 consecutive cases in four years","volume":"13","author":"Gamberi","year":"2011","journal-title":"J Mol Diagn"},{"key":"R3-17-20240829","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.anndiagpath.2016.03.002","article-title":"Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases","volume":"22","author":"Machado","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"R4-17-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/856190","article-title":"Pathobiologic markers of the Ewing sarcoma family of tumors: State of the art and prediction of behaviour","volume":"2011","author":"Pinto","year":"2011","journal-title":"Sarcoma"},{"key":"R5-17-20240829","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.pdm.0000140192.27878.97","article-title":"Molecular diagnosis of Ewing's sarcoma\/primitive neuroectodermal tumor in formalin-fixed paraffin-embedded tissues by RT-PCR and fluorescence in situ hybridization","volume":"14","author":"Qian","year":"2005","journal-title":"Diagn Mol Pathol"},{"key":"R6-17-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.3800486","article-title":"Molecular diagnosis of Ewing sarcoma\/primitive neuroectodermal tumor in routinely processed tissue: A comparison of two FISH strategies and RT-PCR in malignant round cell tumors","volume":"19","author":"Bridge","year":"2006","journal-title":"Mod Pathol"},{"key":"R7-17-20240829","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/bjc.2017.4","article-title":"The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities","volume":"116","author":"Noujaim","year":"2017","journal-title":"Br J Cancer"},{"key":"R8-17-20240829","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/his.12281","article-title":"Round cell sarcomas beyond Ewing: Emerging entities","volume":"64","author":"Antonescu","year":"2014","journal-title":"Histopathology"},{"key":"R9-17-20240829","doi-asserted-by":"crossref","first-page":"674","DOI":"10.5858\/arpa.2014-0234-RA","article-title":"Angiomatoid fibrous histiocytoma: The current status of pathology and genetics","volume":"139","author":"Thway","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"R10-17-20240829","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.5858\/2006-130-1813-CAORHI","article-title":"Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymer-ase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors","volume":"130","author":"Jambhekar","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R11-17-20240829","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12253-013-9721-2","article-title":"Clinicopathological and molecular spectrum of Ewing sarcomas\/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases","volume":"20","author":"Rekhi","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"R12-17-20240829","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/gcc.22376","article-title":"Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results","volume":"55","author":"Huang","year":"2016","journal-title":"Gene Chromosome Canc"},{"key":"R13-17-20240829","first-page":"4568","article-title":"FUS\/ERG gene fusions in Ewing's tumors","volume":"63","author":"Shing","year":"2003","journal-title":"Cancer Res"},{"key":"R14-17-20240829","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cancergencyto.2009.06.002","article-title":"Ewing sarcoma-peripheral neuroecto-dermal tumor of the kidney with a FUS-ERG fusion transcript","volume":"194","author":"Berg","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"R15-17-20240829","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2353\/jmoldx.2007.070009","article-title":"Ewing sarcoma with novel translocation t (2;16) producing an in-frame fusion of FUS and FEV","volume":"9","author":"Ng","year":"2007","journal-title":"J Mol Diagn"},{"key":"R16-17-20240829","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2353\/jmoldx.2007.070053","article-title":"Undifferentiated small round cell sarcomas with rare EWS gene fusions: Identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions","volume":"9","author":"Wang","year":"2007","journal-title":"J Mol Diagn"},{"key":"R17-17-20240829","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/gcc.22172","article-title":"Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: Further evidence toward distinct pathologic entities","volume":"53","author":"Specht","year":"2014","journal-title":"Gene Chromosome Canc"},{"key":"R18-17-20240829","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","article-title":"Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: A clinicopathologic and molecular study of 115 cases","volume":"41","author":"Antonescu","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R19-17-20240829","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pathol.2019.09.015","article-title":"Undifferentiated round cell sarcomas with CIC- DUX4 gene fusion: Expanding clinical spectrum","volume":"52","author":"Brcic","year":"2020","journal-title":"Pathology"},{"key":"R20-17-20240829","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jclinpath-2015-203380","article-title":"Ancillary molecular analysis in the diagnosis of soft tissue tumours: Reassessment of its utility at a specialist centre","volume":"69","author":"Vroobel","year":"2016","journal-title":"J Clin Pathol"},{"key":"R21-17-20240829","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.path.2017.04.001","article-title":"Ewing Sarcoma, an update on molecular pathology with therapeutic Implications","volume":"10","author":"de Alava","year":"2017","journal-title":"Surg Pathol Clin"},{"key":"R23-17-20240829","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00428-009-0842-7","article-title":"Histological heterogeneity of Ewing's sarcoma\/PNET: An immunohistochemical analysis of 415 genetically confirmed cases with clinical support","volume":"455","author":"Llombart-Bosch","year":"2009","journal-title":"Virchows Arch"},{"key":"R24-17-20240829","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0000000000000772","article-title":"DUX4 immunohisto-chemistry is a highly sensitive and specific marker for CIC- DUX4 fusion-positive round cell tumor","volume":"41","author":"Siegele","year":"2017","journal-title":"Am J Surg Pathol"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_267_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:33:54Z","timestamp":1787067234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_267_20"}},"subtitle":["Experience from a tertiary care cancer center"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_267_20","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}